2 days Ago
DUBLIN , Jan. 2, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS ) announced today that its Chief Executive Officer, Richard Pops , will provide a corporate overview and update at the 43 rd Annual J.P.
Morgan Healthcare Conference. The presentation will take place on Wednesday, Jan. 15, 2025 at 11:15 a.
m. PST ( 2:15 p.m.
EST / 7:15 p.m. GMT ), followed by a question and answer session.
The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.
About Alkermes plc Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy and idiopathic hypersomnia . Headquartered in Ireland , Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio .
For more information, please visit Alkermes ' website at www.alkermes.com .
Alkermes Contact: Jamie Constantine Investor Relations +1 781 873 2402 SOURCE Alkermes plc.
